Osimertinib as Salvage Therapy in Advanced Non-Small Cell Lung Cancer After Aumolertinib Resistance With T790M Mutation: A Case Report.

• Tác giả: Qingle Chen, Xiaoling Chen, Jie Huang, Taihe Lan, Taihua Liao, Jianping Lu, Li Ren, Yongtong Tang, Jilan Xu, Hui Yi, Jun Zhang
• Ngôn ngữ: eng
• Ký hiệu phân loại: 910.46809 Accounts of travel and facilities for travelers
• Thông tin xuất bản: England : Clinical case reports , 2025
• Bộ sưu tập: NCBI
• ID: 209979

Tóm tắt

The third generation of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) is recommended universally as the standard treatment for non-small cell lung cancer (NSCLC) carrying the